TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs10259199
log Bayes Factor = 0.247294
Chromosome 7   position 7,848,912  (GRCh37) Explore rs10259199 on Ensembl!
Variant rs10259199 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
K76 Other diseases of liver
0.000 0.588 0.412
K76.9 Liver disease, unspecified
0.000 0.594 0.406
K76.8 Other specified diseases of liver
0.000 0.608 0.392
K70-K77 Diseases of liver
0.000 0.632 0.368
K76.6 Portal hypertension
0.000 0.635 0.365
K76.0 Fatty (change of) liver, not elsewhere classified
0.000 0.650 0.350
K75 Other inflammatory liver diseases
0.000 0.669 0.331
K74 Fibrosis and cirrhosis of liver
0.000 0.672 0.328
K70 Alcoholic liver disease
0.000 0.680 0.320
K76.7 Hepatorenal syndrome
0.000 0.683 0.317
K70.1 Alcoholic hepatitis
0.000 0.698 0.302
K74.6 Other and unspecified cirrhosis of liver
0.000 0.698 0.302
K75.4 Autoimmune hepatitis
0.000 0.704 0.296
K76.5 Hepatic veno-occlusive disease
0.000 0.705 0.295
K76.4 Peliosis hepatis
0.000 0.705 0.295
K76.3 Infarction of liver
0.000 0.705 0.295
K76.2 Central haemorrhagic necrosis of liver
0.000 0.705 0.295
K76.1 Chronic passive congestion of liver
0.000 0.705 0.295
K75.9 Inflammatory liver disease, unspecified
0.000 0.717 0.283
K70.4 Alcoholic hepatic failure
0.000 0.732 0.268
K73 Chronic hepatitis, not elsewhere classified
0.000 0.732 0.268
K77 Liver disorders in diseases classified elsewhere
0.000 0.736 0.264
K71 Toxic liver disease
0.000 0.736 0.264
K75.8 Other specified inflammatory liver diseases
0.000 0.741 0.259
K74.0 Hepatic fibrosis
0.000 0.751 0.248
K75.3 Granulomatous hepatitis, not elsewhere classified
0.000 0.762 0.238
K75.2 Nonspecific reactive hepatitis
0.000 0.762 0.238
K75.1 Phlebitis of portal vein
0.000 0.762 0.238
K74.4 Secondary biliary cirrhosis
0.000 0.764 0.236
K74.2 Hepatic fibrosis with hepatic sclerosis
0.000 0.764 0.236
K74.1 Hepatic sclerosis
0.000 0.764 0.236
K74.5 Biliary cirrhosis, unspecified
0.000 0.768 0.232
K70.3 Alcoholic cirrhosis of liver
0.000 0.775 0.225
K70.2 Alcoholic fibrosis and sclerosis of liver
0.000 0.777 0.223
K70.0 Alcoholic fatty liver
0.000 0.778 0.222
K74.3 Primary biliary cirrhosis
0.000 0.781 0.219
K72 Hepatic failure, not elsewhere classified
0.000 0.782 0.218
K73.2 Chronic active hepatitis, not elsewhere classified
0.000 0.782 0.217
K73.8 Other chronic hepatitis, not elsewhere classified
0.000 0.808 0.192
K73.1 Chronic lobular hepatitis, not elsewhere classified
0.000 0.808 0.192
K73.0 Chronic persistent hepatitis, not elsewhere classified
0.000 0.808 0.192
K71.9 Toxic liver disease, unspecified
0.000 0.811 0.189
K71.8 Toxic liver disease with other disorders of liver
0.000 0.811 0.189
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver
0.000 0.811 0.189
K71.6 Toxic liver disease with hepatitis, not elsewhere classified
0.000 0.811 0.189
K71.5 Toxic liver disease with chronic active hepatitis
0.000 0.811 0.189
K71.4 Toxic liver disease with chronic lobular hepatitis
0.000 0.811 0.189
K71.3 Toxic liver disease with chronic persistent hepatitis
0.000 0.811 0.189
K71.2 Toxic liver disease with acute hepatitis
0.000 0.811 0.189
K71.1 Toxic liver disease with hepatic necrosis
0.000 0.811 0.189
K71.0 Toxic liver disease with cholestasis
0.000 0.811 0.189
K77.8 Liver disorders in other diseases classified elsewhere
0.000 0.811 0.189
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere
0.000 0.811 0.189
K73.9 Chronic hepatitis, unspecified
0.000 0.840 0.160
K72.1 Chronic hepatic failure
0.000 0.843 0.156
K75.0 Abscess of liver
0.000 0.847 0.153
K72.9 Hepatic failure, unspecified
0.000 0.857 0.143
K72.0 Acute and subacute hepatic failure
0.000 0.869 0.130
K70.9 Alcoholic liver disease, unspecified
0.000 0.910 0.090
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.944 0.056
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.946 0.054
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.947 0.053
T43.2 Other and unspecified antidepressants
0.000 0.949 0.051
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.952 0.048
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.952 0.048
T45.0 Antiallergic and antiemetic drugs
0.000 0.955 0.045
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.955 0.045
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.956 0.044
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.956 0.044
T42.4 Benzodiazepines
0.000 0.956 0.044
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.957 0.043
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.957 0.043
J40-J47 Chronic lower respiratory diseases
0.000 0.958 0.042
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.958 0.042
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.958 0.042
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.959 0.041
J46 Status asthmaticus
0.000 0.959 0.041
T43.9 Psychotropic drug, unspecified
0.000 0.960 0.040
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.960 0.040
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.960 0.040
T43.6 Psychostimulants with abuse potential
0.000 0.960 0.040
J42 Unspecified chronic bronchitis
0.000 0.960 0.040
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.961 0.039
T36 Poisoning by systemic antibiotics
0.000 0.961 0.039
J45 Asthma
0.000 0.961 0.039
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.961 0.039
J45.0 Predominantly allergic asthma
0.000 0.961 0.039
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.962 0.038
J44.8 Other specified chronic obstructive pulmonary disease
0.000 0.962 0.038
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.962 0.038
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.962 0.038
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.962 0.038
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.962 0.038
J44 Other chronic obstructive pulmonary disease
0.000 0.962 0.038
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.963 0.037
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.964 0.036
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.964 0.036
T42.1 Iminostilbenes
0.000 0.964 0.036
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.964 0.036
J93.9 Pneumothorax, unspecified
0.000 0.964 0.036
J43 Emphysema
0.000 0.964 0.036
J90-J94 Other diseases of pleura
0.000 0.965 0.035
T45.5 Anticoagulants
0.000 0.965 0.035
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.965 0.035
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.965 0.035
T42.3 Barbiturates
0.000 0.965 0.035
T42.2 Succinimides and oxazolidinediones
0.000 0.965 0.035
T42.0 Hydantoin derivatives
0.000 0.965 0.035
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.965 0.035
T45.8 Other primarily systemic and haematological agents
0.000 0.965 0.035
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.965 0.035
T45.6 Fibrinolysis-affecting drugs
0.000 0.965 0.035
T45.4 Iron and its compounds
0.000 0.965 0.035
T45.3 Enzymes, not elsewhere classified
0.000 0.965 0.035
T45.2 Vitamins, not elsewhere classified
0.000 0.965 0.035
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.965 0.035
J90 Pleural effusion, not elsewhere classified
0.000 0.965 0.035
J93 Pneumothorax
0.000 0.966 0.034
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.967 0.033
J40 Bronchitis, not specified as acute or chronic
0.000 0.967 0.033
J94 Other pleural conditions
0.000 0.968 0.032
T40.2 Other opioids
0.000 0.968 0.032
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.968 0.032
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.968 0.032
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.968 0.032
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.968 0.032
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.968 0.032
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.968 0.032
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.968 0.032
T44.0 Anticholinesterase agents
0.000 0.968 0.032
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.969 0.031
T50.8 Diagnostic agents
0.000 0.969 0.031
T50.7 Analeptics and opioid receptor antagonists
0.000 0.969 0.031
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.969 0.031
T50.5 Appetite depressants
0.000 0.969 0.031
T50.4 Drugs affecting uric acid metabolism
0.000 0.969 0.031
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.969 0.031
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.969 0.031
T50.1 Loop [high-ceiling] diuretics
0.000 0.969 0.031
T50.0 Mineralocorticoids and their antagonists
0.000 0.969 0.031
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.969 0.031
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.969 0.031
T46.7 Peripheral vasodilators
0.000 0.969 0.031
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.969 0.031
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.969 0.031
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.969 0.031
J43.9 Emphysema, unspecified
0.000 0.969 0.031
J41 Simple and mucopurulent chronic bronchitis
0.000 0.969 0.031
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.969 0.030
T38.9 Other and unspecified hormone antagonists
0.000 0.970 0.030
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.970 0.030
T38.7 Androgens and anabolic congeners
0.000 0.970 0.030
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.970 0.030
T38.5 Other oestrogens and progestogens
0.000 0.970 0.030
T38.4 Oral contraceptives
0.000 0.970 0.030
T38.2 Antithyroid drugs
0.000 0.970 0.030
T38.0 Glucocorticoids and synthetic analogues
0.000 0.970 0.030
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.970 0.030
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.970 0.030
T47.7 Emetics
0.000 0.970 0.030
T47.6 Antidiarrhoeal drugs
0.000 0.970 0.030
T47.5 Digestants
0.000 0.970 0.030
T47.4 Other laxatives
0.000 0.970 0.030
T47.3 Saline and osmotic laxatives
0.000 0.970 0.030
T47.2 Stimulant laxatives
0.000 0.970 0.030
T47.0 Histamine H(2)-receptor antagonists
0.000 0.970 0.030
J91 Pleural effusion in conditions classified elsewhere
0.000 0.970 0.030
T36.0 Penicillins
0.000 0.970 0.029
J94.2 Haemothorax
0.000 0.971 0.029
J44.9 Chronic obstructive pulmonary disease, unspecified
0.000 0.971 0.029
T36.9 Systemic antibiotic, unspecified
0.000 0.971 0.028
T36.8 Other systemic antibiotics
0.000 0.971 0.028
T36.7 Antifungal antibiotics, systemically used
0.000 0.971 0.028
T36.6 Rifamycins
0.000 0.971 0.028
T36.5 Aminoglycosides
0.000 0.971 0.028
T36.4 Tetracyclines
0.000 0.971 0.028
T36.3 Macrolides
0.000 0.971 0.028
T36.2 Chloramphenicol group
0.000 0.971 0.028
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.971 0.028
J45.8 Mixed asthma
0.000 0.972 0.028
J45.1 Nonallergic asthma
0.000 0.972 0.028
T46.1 Calcium-channel blockers
0.000 0.972 0.028
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.972 0.028
T40.8 Lysergide [LSD]
0.000 0.972 0.028
T40.7 Cannabis (derivatives)
0.000 0.972 0.028
T40.5 Cocaine
0.000 0.972 0.028
T40.3 Methadone
0.000 0.972 0.028
T40.1 Heroin
0.000 0.972 0.028
T40.0 Opium
0.000 0.972 0.028
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.972 0.027
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.972 0.027
T37.5 Antiviral drugs
0.000 0.972 0.027
T37.4 Anthelminthics
0.000 0.972 0.027
T37.3 Other antiprotozoal drugs
0.000 0.972 0.027
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.972 0.027
T37.1 Antimycobacterial drugs
0.000 0.972 0.027
T37.0 Sulphonamides
0.000 0.972 0.027
T41.5 Therapeutic gases
0.000 0.972 0.027
T41.4 Anaesthetic, unspecified
0.000 0.972 0.027
T41.3 Local anaesthetics
0.000 0.972 0.027
T41.2 Other and unspecified general anaesthetics
0.000 0.972 0.027
T41.1 Intravenous anaesthetics
0.000 0.972 0.027
T41.0 Inhaled anaesthetics
0.000 0.972 0.027
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.972 0.027
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.972 0.027
T48.5 Anti-common-cold drugs
0.000 0.972 0.027
T48.4 Expectorants
0.000 0.972 0.027
T48.3 Antitussives
0.000 0.972 0.027
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.972 0.027
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.972 0.027
T48.0 Oxytocic drugs
0.000 0.972 0.027
T49.9 Topical agent, unspecified
0.000 0.972 0.027
T49.8 Other topical agents
0.000 0.972 0.027
T49.7 Dental drugs, topically applied
0.000 0.972 0.027
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.972 0.027
T49.5 Ophthalmological drugs and preparations
0.000 0.972 0.027
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.972 0.027
T49.3 Emollients, demulcents and protectants
0.000 0.972 0.027
T49.2 Local astringents and local detergents
0.000 0.972 0.027
T49.1 Antipruritics
0.000 0.972 0.027
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.972 0.027
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified
0.000 0.972 0.028
Chapter X Diseases of the respiratory system
0.000 0.972 0.028
J94.8 Other specified pleural conditions
0.000 0.973 0.027
T40.6 Other and unspecified narcotics
0.000 0.974 0.026
E66.9 Obesity, unspecified
0.000 0.974 0.026
J43.8 Other emphysema
0.000 0.974 0.026
J43.1 Panlobular emphysema
0.000 0.974 0.026
J43.0 MacLeod's syndrome
0.000 0.974 0.026
T38.1 Thyroid hormones and substitutes
0.000 0.974 0.025
J93.8 Other pneumothorax
0.000 0.975 0.025
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.975 0.025
J43.2 Centrilobular emphysema
0.000 0.975 0.025
J94.9 Pleural condition, unspecified
0.000 0.976 0.023
J94.0 Chylous effusion
0.000 0.976 0.023
J93.0 Spontaneous tension pneumothorax
0.000 0.977 0.023
J45.9 Asthma, unspecified
0.000 0.977 0.023
J94.1 Fibrothorax
0.000 0.977 0.023
J20-J22 Other acute lower respiratory infections
0.000 0.978 0.022
J85-J86 Suppurative and necrotic conditions of lower respiratory tract
0.000 0.978 0.022
T40.4 Other synthetic narcotics
0.000 0.978 0.022
J41.8 Mixed simple and mucopurulent chronic bronchitis
0.000 0.978 0.022
J41.1 Mucopurulent chronic bronchitis
0.000 0.978 0.022
J41.0 Simple chronic bronchitis
0.000 0.978 0.022
J95-J99 Other diseases of the respiratory system
0.000 0.979 0.021
J20 Acute bronchitis
0.000 0.979 0.021
J20.9 Acute bronchitis, unspecified
0.000 0.980 0.020
J99 Respiratory disorders in diseases classified elsewhere
0.000 0.981 0.019
J93.1 Other spontaneous pneumothorax
0.000 0.981 0.019
J86 Pyothorax
0.000 0.981 0.019
J99.8 Respiratory disorders in other diseases classified elsewhere
0.000 0.982 0.018
J95 Postprocedural respiratory disorders, not elsewhere classified
0.000 0.983 0.017
J86.9 Pyothorax without fistula
0.000 0.983 0.017
J21 Acute bronchiolitis
0.000 0.984 0.016
J85 Abscess of lung and mediastinum
0.000 0.984 0.016
J96 Respiratory failure, not elsewhere classified
0.000 0.985 0.015
J20.8 Acute bronchitis due to other specified organisms
0.000 0.985 0.015
J20.7 Acute bronchitis due to echovirus
0.000 0.985 0.015
J20.6 Acute bronchitis due to rhinovirus
0.000 0.985 0.015
J20.5 Acute bronchitis due to respiratory syncytial virus
0.000 0.985 0.015
J20.4 Acute bronchitis due to parainfluenza virus
0.000 0.985 0.015
J20.3 Acute bronchitis due to coxsackie virus
0.000 0.985 0.015
J20.2 Acute bronchitis due to streptococcus
0.000 0.985 0.015
J20.1 Acute bronchitis due to Haemophilus influenzae
0.000 0.985 0.015
J20.0 Acute bronchitis due to Mycoplasma pneumoniae
0.000 0.985 0.015
J99.1 Respiratory disorders in other diffuse connective tissue disorders
0.000 0.985 0.015
J60-J70 Lung diseases due to external agents
0.000 0.985 0.015
J80-J84 Other respiratory diseases principally affecting the interstitium
0.000 0.985 0.014
J95.0 Tracheostomy malfunction
0.000 0.986 0.014
J99.0 Rheumatoid lung disease
0.000 0.986 0.013
J84 Other interstitial pulmonary diseases
0.000 0.987 0.013
J86.0 Pyothorax with fistula
0.000 0.987 0.013
J67 Hypersensitivity pneumonitis due to organic dust
0.000 0.987 0.012
J09-J18 Influenza and pneumonia
0.000 0.987 0.012
J95.9 Postprocedural respiratory disorder, unspecified
0.000 0.988 0.012
J95.8 Other postprocedural respiratory disorders
0.000 0.988 0.012
J95.5 Postprocedural subglottic stenosis
0.000 0.988 0.012
J95.4 Mendelson's syndrome
0.000 0.988 0.012
J95.3 Chronic pulmonary insufficiency following surgery
0.000 0.988 0.012
J95.2 Acute pulmonary insufficiency following nonthoracic surgery
0.000 0.988 0.012
J95.1 Acute pulmonary insufficiency following thoracic surgery
0.000 0.988 0.012
J10.1 Influenza with other respiratory manifestations, influenza virus identified
0.000 0.988 0.012
J10 Influenza due to identified influenza virus
0.000 0.988 0.012
J21.9 Acute bronchiolitis, unspecified
0.000 0.988 0.012
J21.8 Acute bronchiolitis due to other specified organisms
0.000 0.988 0.012
J21.1 Acute bronchiolitis due to human metapneumovirus
0.000 0.988 0.012
J21.0 Acute bronchiolitis due to respiratory syncytial virus
0.000 0.988 0.012
J85.3 Abscess of mediastinum
0.000 0.988 0.012
J85.1 Abscess of lung with pneumonia
0.000 0.988 0.012
J85.0 Gangrene and necrosis of lung
0.000 0.988 0.012
D48.1 Connective and other soft tissue
0.012 0.988 0.000
J85.2 Abscess of lung without pneumonia
0.000 0.988 0.012
J84.1 Other interstitial pulmonary diseases with fibrosis
0.000 0.988 0.012
J84.8 Other specified interstitial pulmonary diseases
0.000 0.988 0.012
J96.9 Respiratory failure, unspecified
0.000 0.989 0.011
J96.1 Chronic respiratory failure
0.000 0.989 0.011
J96.0 Acute respiratory failure
0.000 0.989 0.011
J92 Pleural plaque
0.000 0.989 0.011
J70 Respiratory conditions due to other external agents
0.000 0.989 0.011
J68 Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours
0.000 0.989 0.011
J66 Airway disease due to specific organic dust
0.000 0.989 0.011
J63 Pneumoconiosis due to other inorganic dusts
0.000 0.989 0.011
J62 Pneumoconiosis due to dust containing silica
0.000 0.989 0.011
J65 Pneumoconiosis associated with tuberculosis
0.000 0.989 0.011
J60 Coalworker's pneumoconiosis
0.000 0.989 0.011
E66 Obesity
0.000 0.989 0.011
J67.9 Hypersensitivity pneumonitis due to unspecified organic dust
0.000 0.989 0.011
J34.8 Other specified disorders of nose and nasal sinuses
0.000 0.989 0.011
S42.20 Fracture of upper end of humerus (closed)
0.011 0.989 0.000
J64 Unspecified pneumoconiosis
0.000 0.989 0.010
J82 Pulmonary eosinophilia, not elsewhere classified
0.000 0.990 0.010
J84.0 Alveolar and parietoalveolar conditions
0.000 0.990 0.010
J22 Unspecified acute lower respiratory infection
0.000 0.990 0.010
J17 Pneumonia in diseases classified elsewhere
0.000 0.990 0.009
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.991 0.009
J12 Viral pneumonia, not elsewhere classified
0.000 0.991 0.009
J67.8 Hypersensitivity pneumonitis due to other organic dusts
0.000 0.991 0.009
J67.7 Air-conditioner and humidifier lung
0.000 0.991 0.009
J67.6 Maple-bark-stripper's lung
0.000 0.991 0.009
J67.5 Mushroom-worker's lung
0.000 0.991 0.009
J67.4 Maltworker's lung
0.000 0.991 0.009
J67.3 Suberosis
0.000 0.991 0.009
J67.2 Bird fancier's lung
0.000 0.991 0.009
J67.1 Bagassosis
0.000 0.991 0.009
J67.0 Farmer's lung
0.000 0.991 0.009
J16 Pneumonia due to other infectious organisms, not elsewhere classified
0.000 0.991 0.009
J09 Influenza due to certain identified influenza virus
0.000 0.991 0.009
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites
0.009 0.991 0.000
J10.0 Influenza with pneumonia, influenza virus identified
0.000 0.991 0.009
J10.8 Influenza with other manifestations, influenza virus identified
0.000 0.991 0.009
J61 Pneumoconiosis due to asbestos and other mineral fibres
0.000 0.991 0.009
J84.9 Interstitial pulmonary disease, unspecified
0.000 0.991 0.009
D48.6 Breast
0.008 0.991 0.000
J96.09 Acute respiratory failure; Type unspecified
0.000 0.992 0.008
J96.01 Acute respiratory failure; Type II [hypercapnic]
0.000 0.992 0.008
J96.00 Acute respiratory failure; Type I [hypoxic]
0.000 0.992 0.008
J96.19 Chronic respiratory failure; Type unspecified
0.000 0.992 0.008
J96.11 Chronic respiratory failure; Type II [hypercapnic]
0.000 0.992 0.008
J96.10 Chronic respiratory failure; Type I [hypoxic]
0.000 0.992 0.008
J96.99 Respiratory failure, unspecified; Type unspecified
0.000 0.992 0.008
J96.91 Respiratory failure unspecified; Type II [hypercapnic]
0.000 0.992 0.008
J96.90 Respiratory failure, unspecified; Type I [hypoxic]
0.000 0.992 0.008
J62.8 Pneumoconiosis due to other dust containing silica
0.000 0.992 0.008
J62.0 Pneumoconiosis due to talc dust
0.000 0.992 0.008
J63.8 Pneumoconiosis due to other specified inorganic dusts
0.000 0.992 0.008
J63.5 Stannosis
0.000 0.992 0.008
J63.4 Siderosis
0.000 0.992 0.008
J63.3 Graphite fibrosis (of lung)
0.000 0.992 0.008
J63.2 Berylliosis
0.000 0.992 0.008
J63.1 Bauxite fibrosis (of lung)
0.000 0.992 0.008
J63.0 Aluminosis (of lung)
0.000 0.992 0.008
J66.8 Airway disease due to other specific organic dusts
0.000 0.992 0.008
J66.2 Cannabinosis
0.000 0.992 0.008
J66.1 Flax-dresser's disease
0.000 0.992 0.008
J66.0 Byssinosis
0.000 0.992 0.008
J68.9 Unspecified respiratory condition due to chemicals, gases, fumes and vapours
0.000 0.992 0.008
J68.8 Other respiratory conditions due to chemicals, gases, fumes and vapours
0.000 0.992 0.008
J68.4 Chronic respiratory conditions due to chemicals, gases, fumes and vapours
0.000 0.992 0.008
J68.3 Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapours
0.000 0.992 0.008
J68.2 Upper respiratory inflammation due to chemicals, gases, fumes and vapours, not elsewhere classified
0.000 0.992 0.008
J68.1 Acute pulmonary oedema due to chemicals, gases, fumes and vapours
0.000 0.992 0.008
J68.0 Bronchitis and pneumonitis due to chemicals, gases, fumes and vapours
0.000 0.992 0.008
J70.9 Respiratory conditions due to unspecified external agent
0.000 0.992 0.008
J70.8 Respiratory conditions due to other specified external agents
0.000 0.992 0.008
J70.4 Drug-induced interstitial lung disorder, unspecified
0.000 0.992 0.008
J70.3 Chronic drug-induced interstitial lung disorders
0.000 0.992 0.008
J70.2 Acute drug-induced interstitial lung disorders
0.000 0.992 0.008
J70.1 Chronic and other pulmonary manifestations due to radiation
0.000 0.992 0.008
J70.0 Acute pulmonary manifestations due to radiation
0.000 0.992 0.008
J34 Other disorders of nose and nasal sinuses
0.000 0.992 0.008
E66.1 Drug-induced obesity
0.000 0.992 0.008
J11 Influenza, virus not identified
0.000 0.992 0.008
D17.1 Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
0.000 0.992 0.008
D47.3 Essential (haemorrhagic) thrombocythaemia
0.008 0.992 0.000
D48.4 Peritoneum
0.008 0.992 0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
0.008 0.992 0.000
E66.0 Obesity due to excess calories
0.000 0.992 0.008
I26.9 Pulmonary embolism without mention of acute cor pulmonale
0.000 0.992 0.008
I67.8 Other specified cerebrovascular diseases
0.000 0.992 0.008
J15 Bacterial pneumonia, not elsewhere classified
0.000 0.992 0.008
J17.3 Pneumonia in parasitic diseases
0.000 0.992 0.007
J34.3 Hypertrophy of nasal turbinates
0.000 0.992 0.008
J17.2 Pneumonia in mycoses
0.000 0.993 0.007
J17.0 Pneumonia in bacterial diseases classified elsewhere
0.000 0.993 0.007
J80 Adult respiratory distress syndrome
0.000 0.993 0.007
J13 Pneumonia due to Streptococcus pneumoniae
0.000 0.993 0.007
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.993 0.007
J17.8 Pneumonia in other diseases classified elsewhere
0.000 0.993 0.007
J12.9 Viral pneumonia, unspecified
0.000 0.993 0.007
T39.4 Antirheumatics, not elsewhere classified
0.000 0.993 0.007
T39.2 Pyrazolone derivatives
0.000 0.993 0.007
J12.8 Other viral pneumonia
0.000 0.993 0.007
J12.3 Human metapneumovirus pneumonia
0.000 0.993 0.007
J12.2 Parainfluenza virus pneumonia
0.000 0.993 0.007
J12.1 Respiratory syncytial virus pneumonia
0.000 0.993 0.007
J12.0 Adenoviral pneumonia
0.000 0.993 0.007
D48.0 Bone and articular cartilage
0.007 0.993 0.000
E66.2 Extreme obesity with alveolar hypoventilation
0.000 0.993 0.007
J16.8 Pneumonia due to other specified infectious organisms
0.000 0.993 0.007
J16.0 Chlamydial pneumonia
0.000 0.993 0.007
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified
0.007 0.993 0.000
D48.3 Retroperitoneum
0.007 0.993 0.000
D48.2 Peripheral nerves and autonomic nervous system
0.007 0.993 0.000
J14 Pneumonia due to Haemophilus influenzae
0.000 0.993 0.007
E65-E68 Obesity and other hyperalimentation
0.000 0.993 0.007
J69 Pneumonitis due to solids and liquids
0.000 0.993 0.006
S42.2 Fracture of upper end of humerus
0.007 0.993 0.000
D37-D48 Neoplasms of uncertain or unknown behaviour
0.007 0.993 0.000
J30-J39 Other diseases of upper respiratory tract
0.000 0.993 0.007
D47.1 Chronic myeloproliferative disease
0.007 0.993 0.000
D47.4 Osteomyelofibrosis
0.007 0.993 0.000
J31 Chronic rhinitis, nasopharyngitis and pharyngitis
0.000 0.993 0.007
E65 Localised adiposity
0.000 0.994 0.006
D41 Neoplasm of uncertain or unknown behaviour of urinary organs
0.006 0.994 0.000
J17.1 Pneumonia in viral diseases classified elsewhere
0.000 0.994 0.006
S02.40 Fracture of malar and maxillary bones (closed)
0.006 0.994 0.000
J31.0 Chronic rhinitis
0.000 0.994 0.006
D47.2 Monoclonal gammopathy
0.006 0.994 0.000
J11.8 Influenza with other manifestations, virus not identified
0.000 0.994 0.006
J11.0 Influenza with pneumonia, virus not identified
0.000 0.994 0.006
D41.0 Kidney
0.006 0.994 0.000
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
0.006 0.994 0.000
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
0.006 0.994 0.000
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]
0.006 0.994 0.000
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour
0.006 0.994 0.000
J15.4 Pneumonia due to other streptococci
0.000 0.994 0.006
S02.4 Fracture of malar and maxillary bones
0.006 0.994 0.000
J15.7 Pneumonia due to Mycoplasma pneumoniae
0.000 0.994 0.006
J15.1 Pneumonia due to Pseudomonas
0.000 0.994 0.006
J15.8 Other bacterial pneumonia
0.000 0.994 0.006
J15.6 Pneumonia due to other aerobic Gram-negative bacteria
0.000 0.994 0.006
J15.3 Pneumonia due to streptococcus, group B
0.000 0.994 0.006
S02 Fracture of skull and facial bones
0.006 0.994 0.000
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs
0.006 0.994 0.000
J34.1 Cyst and mucocele of nose and nasal sinus
0.000 0.994 0.006
J31.2 Chronic pharyngitis
0.000 0.994 0.006
T39.0 Salicylates
0.000 0.994 0.005
J15.2 Pneumonia due to staphylococcus
0.000 0.994 0.005
J15.5 Pneumonia due to Escherichia coli
0.000 0.995 0.005
S02.6 Fracture of mandible
0.005 0.995 0.000
S02.60 Fracture of mandible (closed)
0.005 0.995 0.000
K12.2 Cellulitis and abscess of mouth
0.005 0.995 0.000
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands
0.005 0.995 0.000
D41.4 Bladder
0.005 0.995 0.000
E66.8 Other obesity
0.000 0.995 0.005
S02.8 Fractures of other skull and facial bones
0.005 0.995 0.000
J15.9 Bacterial pneumonia, unspecified
0.000 0.995 0.005
J98 Other respiratory disorders
0.000 0.995 0.005
D17.9 Benign lipomatous neoplasm, unspecified
0.000 0.995 0.005
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.995 0.005
E67 Other hyperalimentation
0.000 0.995 0.005
E68 Sequelae of hyperalimentation
0.000 0.995 0.005
S02.80 Fractures of other skull and facial bones (closed)
0.005 0.995 0.000
D48.5 Skin
0.005 0.995 0.000
J69.1 Pneumonitis due to oils and essences
0.000 0.995 0.005
S02.7 Multiple fractures involving skull and facial bones
0.005 0.995 0.000
S42.21 Fracture of upper end of humerus (open)
0.005 0.995 0.000
H65.9 Nonsuppurative otitis media, unspecified
0.005 0.995 0.000
D42 Neoplasm of uncertain or unknown behaviour of meninges
0.005 0.995 0.000
S02.5 Fracture of tooth
0.005 0.995 0.000
C49.1 Connective and soft tissue of upper limb, including shoulder
0.005 0.995 0.000
J31.1 Chronic nasopharyngitis
0.000 0.995 0.005
J37 Chronic laryngitis and laryngotracheitis
0.000 0.995 0.005
D38.0 Larynx
0.005 0.995 0.000
H65.4 Other chronic nonsuppurative otitis media
0.005 0.995 0.000
D41.9 Urinary organ, unspecified
0.005 0.995 0.000
D41.7 Other urinary organs
0.005 0.995 0.000
D41.3 Urethra
0.005 0.995 0.000
D41.2 Ureter
0.005 0.995 0.000
D41.1 Renal pelvis
0.005 0.995 0.000
H65 Nonsuppurative otitis media
0.005 0.995 0.000
J69.8 Pneumonitis due to other solids and liquids
0.000 0.995 0.004
R07.3 Other chest pain
0.000 0.995 0.005
C49 Malignant neoplasm of other connective and soft tissue
0.005 0.995 0.000
S02.70 Multiple fractures involving skull and facial bones (closed)
0.005 0.995 0.000
D48.7 Other specified sites
0.004 0.995 0.000
J34.2 Deviated nasal septum
0.000 0.995 0.005
J00-J06 Acute upper respiratory infections
0.000 0.995 0.005
J11.1 Influenza with other respiratory manifestations, virus not identified
0.000 0.995 0.005
D46 Myelodysplastic syndromes
0.005 0.995 0.000
S02.50 Fracture of tooth (closed)
0.005 0.995 0.000
S02.3 Fracture of orbital floor
0.005 0.995 0.000
D44.4 Craniopharyngeal duct
0.005 0.995 0.000
J15.0 Pneumonia due to Klebsiella pneumoniae
0.000 0.995 0.004
C49.3 Connective and soft tissue of thorax
0.005 0.995 0.000
H65.2 Chronic serous otitis media
0.005 0.995 0.000
N13.8 Other obstructive and reflux uropathy
0.000 0.995 0.005
J34.0 Abscess, furuncle and carbuncle of nose
0.000 0.995 0.004
S02.9 Fracture of skull and facial bones, part unspecified
0.004 0.995 0.000
D45 Polycythaemia vera
0.004 0.995 0.000
S02.41 Fracture of malar and maxillary bones (open)
0.004 0.996 0.000
C49.2 Connective and soft tissue of lower limb, including hip
0.004 0.996 0.000
D40 Neoplasm of uncertain or unknown behaviour of male genital organs
0.004 0.996 0.000
T39.1 4-Aminophenol derivatives
0.000 0.996 0.004
C49.9 Connective and soft tissue, unspecified
0.004 0.996 0.000
D38.6 Respiratory organ, unspecified
0.004 0.996 0.000
D38.5 Other respiratory organs
0.004 0.996 0.000
D38.4 Thymus
0.004 0.996 0.000
D38.3 Mediastinum
0.004 0.996 0.000
D38.2 Pleura
0.004 0.996 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.